Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Yan QC et al. | 1998 | animal, rat/Wistar, partial body: femur | static magnetic field | 180 mT |
Blackman CF et al. | 1998 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, low frequency, DC, static magnetic field | 23.8–36.6 µT |
Nakamura K et al. | 1997 | bacterium, <i>Bacillus subtilis</i>/MI13 (normal or transformed with plasmid pC112 to enable the synthesis of surfactin (a cyclic lipopeptide antibiotic)) | static magnetic field, DC | 5.2–7 T |
Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
Reipert BM et al. | 1996 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2–65 µT |
Raylman RR et al. | 1996 | intact cell/cell culture, HTB 63 (melanoma cells), HTB 77 IP3 (ovarian carcinoma cells) and CCL 86 (lymphoma cells) | static magnetic field | 7 T |
Tanioka N et al. | 1996 | intact cell/cell culture, B16C2 (murine melanoma cells) and EL-4 (murine T-lymphoma cells) | static magnetic field, MRI | 6.34 T |
Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
Linder-Aronson A et al. | 1995 | intact cell/cell culture, fibroblasts | static magnetic field | 280 mT |
Mahdi A et al. | 1994 | bacterium, <i>Escherichia coli</i> | static magnetic field, DC, also other exposures without EMF | 0.5–3 T |
Malko JA et al. | 1994 | intact cell/cell culture, yeast <i>Saccharomyces cerevisiae</i> | static magnetic field, MRI | 1.49 T |
Norimura T et al. | 1993 | intact cell/cell culture, human T-lymphocytes | static magnetic field, DC, co-exposure | 6.3 T |
McDonald F | 1993 | intact cell/cell culture, rat osteoblasts and fibroblasts | static magnetic field | 450–610 mT |
Yamaguchi H et al. | 1993 | intact cell/cell culture, human gingival fibroblasts | static magnetic field | 200 mT |
Papadopulos MA et al. | 1992 | intact cell/cell culture, osteoblasts | static magnetic field | 178 mT |
Sato K et al. | 1992 | intact cell/cell culture, HeLa S3 (human cervical carcinoma cell line) | static magnetic field | 0.2 T |
Short WO et al. | 1992 | intact cell/cell culture, PS1273 (human malignant melanoma cell line) and DMD-A (human fibroblasts) | static magnetic field, MRI | 500 mT–4.7 T |
Hiraoka M et al. | 1992 | intact cell/cell culture, HeLa S3 (human cervical carcinoma cell line) | static magnetic field | 0.18–0.2 T |
Ross SM | 1990 | intact cell/cell culture, rabbit-ligament fibroblast (RLF) cell line | magnetic field, low frequency, 50/60 Hz, DC, static magnetic field | 42–261 µT |
Sula L et al. | 1982 | virus/bacteriophages, mycobacterial phages No. 308 (isolated from a lysogenic Argentinian bovine strain) and 33 D | static magnetic field | - |
Esformes I et al. | 1981 | intact cell/cell culture, JY human lymphocytes, WI-18 human embryonic fibroblasts, LM mouse embryo fibroblast, animal, rat | static magnetic field | 50 mT |
Iwasaki T et al. | 1978 | intact cell/cell culture, CHO (Chinese hamster ovary) cells, slime mold plasmodia (<i>Physarum polycepharum</i>), animal, frog embryos (<i>Xenopus laevis</i>) | static magnetic field, DC | 500 mT |
Rockwell S | 1977 | intact cell/cell culture, EMT6 (mouse mammary tumour cells) | static magnetic field, co-exposure | 0.138–0.142 T |
Malinin GI et al. | 1976 | intact cell/cell culture, murine L929 fibroblast cells and WI38 cells (human lung fibroblasts) | static magnetic field, DC | 397,887.36 A/m |
Butler BC et al. | 1964 | intact cell/cell culture, KB cells | static magnetic field | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.